Twist Bioscience Quarterly Balance Sheet
NASDAQ: TWSTHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Twist Bioscience financial position
As of Jun 30, 2026, Twist Bioscience reported total assets of $672.4 million, up 4.5% from a year earlier against total liabilities of $226.7 million. Shareholders' equity stood at $445.7 million, or 66.3% of assets. The company held $117.4 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 2.67, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Twist Bioscience balance sheet (quarterly)
| Quarter (USD) | Q3 20262026-06-30 | Q2 20262026-03-31 | Q1 20262025-12-31 | Q4 20252025-09-30 | Q3 20252025-06-30 | Q2 20252025-03-31 | Q1 20252024-12-31 | Q4 20242024-09-30 | Q3 20242024-06-30 | Q2 20242024-03-31 | Q1 20242023-12-31 | Q4 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 117.44M | 122.67M | 148.59M | 183.05M | 201.37M | 210.44M | 221.40M | 226.32M | 239.14M | 243.35M | 266.27M | 286.47M |
| Short-Term Investments | 49.40M | 49.00M | 49.36M | 49.38M | 49.42M | 46.71M | 49.42M | 50.08M | 50.28M | 49.99M | 44.88M | 49.94M |
| Receivables | 65.06M | 64.15M | 50.06M | 57.02M | 49.85M | 49.95M | 39.31M | 34.90M | 31.99M | 35.99M | 35.35M | 44.06M |
| Inventory | 35.16M | 33.52M | 32.92M | 28.31M | 25.94M | 20.86M | 23.52M | 24.08M | 28.48M | 30.38M | 30.86M | 32.06M |
| Total Current Assets | 321.30M | 323.44M | 303.88M | 332.97M | 339.78M | 338.44M | 345.31M | 346.78M | 361.83M | 371.87M | 390.23M | 424.26M |
| Property, Plant & Equipment | 111.89M | 111.23M | 105.12M | 102.28M | 95.35M | 97.14M | 100.67M | 102.52M | 106.34M | 121.34M | 126.22M | 131.83M |
| Goodwill | 82.19M | 82.19M | 82.19M | 82.19M | 82.19M | 85.81M | 85.81M | 85.81M | 85.81M | 85.81M | 85.81M | 85.81M |
| Intangible Assets | 12.73M | 13.00M | 13.16M | 13.43M | 13.69M | 13.95M | 14.21M | 14.48M | 14.74M | 51.90M | 53.19M | 54.48M |
| Total Assets | 672.44M | 676.21M | 638.09M | 641.86M | 643.61M | 595.62M | 608.58M | 614.32M | 638.12M | 702.85M | 732.82M | 776.40M |
| Accounts Payable | 17.04M | 14.68M | 12.49M | 11.09M | 11.98M | 8.06M | 7.50M | 1.63M | 6.63M | 7.70M | 9.26M | 14.05M |
| Total Current Liabilities | 120.25M | 119.98M | 80.44M | 91.41M | 87.07M | 74.98M | 69.65M | 71.01M | 73.76M | 67.49M | 65.23M | 73.32M |
| Total Liabilities | 226.70M | 221.12M | 181.99M | 168.90M | 165.41M | 155.51M | 152.64M | 141.63M | 146.98M | 142.72M | 142.77M | 152.97M |
| Shareholders' Equity | 445.74M | 455.09M | 456.10M | 472.96M | 478.20M | 440.11M | 455.94M | 472.69M | 491.14M | 560.13M | 590.04M | 623.43M |
| Retained Earnings | -1.43B | -1.39B | -1.35B | -1.32B | -1.29B | -1.31B | -1.27B | -1.24B | -1.21B | -1.12B | -1.08B | -1.03B |
| Net Cash (Debt) | 166.84M | 171.67M | 197.95M | 232.43M | 250.80M | 257.15M | 270.83M | 276.40M | 289.42M | 293.34M | 311.14M | 336.41M |
| Shares Outstanding | 62.67M | 62.15M | 61.27M | 60.63M | 60.17M | 59.86M | 59.58M | 58.88M | 58.52M | 58.16M | 57.78M | 57.56M |
This table shows 12 quarterly periods of Twist Bioscience's balance sheet, from Q3 2026 back to Q4 2023, across 20 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow TWST's reporting calendar. What is a balance sheet?